×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: Hot Topics – Handling Emerging Trends in Pharmacovigilance
Session Chair(s)
Barbara Morollo, RN
Head, Pharmacovigilance
Corbus Pharmaceuticals, United States
Catherine Baldridge, MSc
Head of Safety
Fusion Pharmaceuticals, United States
This session will explore three hot topics and emerging trends in pharmacovigilance which include spanning discussions regarding predictive safety using translational data and non-clinical data for predicting ADRs, the impact of cannabinoids as therapeutics and research into the endocannabinoid system.
Learning Objective : At the conclusion of this session, participants should be able to:- Understand the technology and factors that contribute to the ability to predict an adverse events or adverse event in a specific population
- Identify the unique regulatory challenges surrounding cannabis and studying therapeutic benefits in investigational research
Speaker(s)
Cannabinoids as Therapeutics
Barbara Morollo, RN
Corbus Pharmaceuticals, United States
Head, Pharmacovigilance
Speaker
Glenn Carroll, MBA
Deloitte, United States
Principal
Yellow Card Biobank
Sarah Vaughan
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Head of Vigilance Operations
Have an account?